title: Antagonism of AND and AND-OR drug mixture discriminations in rats.
abstract: It has been suggested that use of the AND-OR training method may be associated with an enhancement of the pharmacological specificity of discriminations based on mixture of drugs. Rats were trained to discriminate a mixture of nicotine (0.4 mg/kg s.c.) plus midazolam (0.2 mg/kg s.c.) from saline (AND-discrimination, n = 8) or to discriminate the mixture from either drug alone (AND-OR discrimination, n = 6). The studies used two-lever operant procedures with food reinforcers presented on a tandem schedule. After discriminations were acquired to 80% accuracy, the nicotine antagonist mecamylamine (0.03 1.0 mg/kg s.c.) and the benzodiazepine antagonist flumazenil (0.32 10 mg kg i.p.) were tested on the response to the mixture of nicotine plus midazolam. The antagonist effects of either mecamylamine or flumazenil given alone were more marked in rats trained under the AND-OR procedure than in rats trained on the AND-discrimination. Similarly, the antagonist effects of mixtures of mecamylamine plus flumazenil were much more potent under the AND-OR than under the AND-discrimination procedure. The AND-OR method reduced the dose of the antagonist mixture needed to produce complete block by a factor of about 10, as compared with the AND-discrimination. These striking differences in sensitivity to antagonists support the view that AND-OR or related procedures may enhance the pharmacological specificity of complex drug discriminations.
authors.affiliation: Section of Behavioural Pharmacology, Institute of Psychiatry, London, UK.
authors.forename: E A
authors.initials: EA
authors.lastname: Mariathasan
authors.forename: I P
authors.initials: IP
authors.lastname: Stolerman
authors.forename: J A
authors.initials: JA
authors.lastname: White
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents; D001245:Association Learning / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects; D004193:Discrimination Learning / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005442:Flumazenil / Q000494:pharmacology*; D018757:GABA Modulators / Q000494:pharmacology*; D008464:Mecamylamine / Q000494:pharmacology*; D008874:Midazolam; D009042:Motivation; D009538:Nicotine; D018733:Nicotinic Antagonists / Q000494:pharmacology*; D051381:Rats; D012055:Reinforcement Schedule; D019966:Substance-Related Disorders / Q000523:psychology*
chemical_list: D014151:Anti-Anxiety Agents; D018757:GABA Modulators; D018733:Nicotinic Antagonists; D005442:Flumazenil; D008464:Mecamylamine; D009538:Nicotine; D008874:Midazolam